Verona's approval of ensifentrine in COPD offers promising potential with its MoA and safety profile in a competitive market.

The first new treatment for asthma attacks in 50 years has been hailed as a "game-changer" by doctors and patients.

The 2025 GOLD COPD report has a new emphasis on CV disease and PH in COPD and major updates on new drugs, climate change, and ...

Benralizumab, a monoclonal antibody, is the first breakthrough in asthma and COPD flare-up treatment in 50 years. Targeting ...

In patients with long COVID, lower pulmonary gas exchange may be associated with impaired cognitive function, according to a ...

Study senior author Dr. Sean Fain said: “If these findings can be generalized to the long Covid population, the study ...

In patients with long COVID, lower pulmonary gas exchange may be associated with impaired cognitive function, according to a study being presented next week at the annual meeting of the Radiological ...

This study documents that anemia occurs relatively frequently in COPD patients and is related to the presence of inflammation. Anemia is an understudied issue in COPD but may be of great ...

Expert Rev Resp Med. 2007;1(3):307-316. © 2007 Future Drugs Ltd. No writing assistance was utilized in the production of this manuscript.

16 By optimising patient-physician understanding of the nature of exacerbations of COPD and the effects of early treatment, the negative influence of the current morbidity and mortality of ...

Researchers Identify Key Mechanism in Human Lung Development ... 2024 — Managing hard-to-treat respiratory illnesses like asthma and pulmonary fibrosis just got easier if a new drug-carrying ...

Ligand Pharmaceuticals' Q3 2024 earnings report beat on the top and bottom lines, reinforcing my confidence. Read what makes ...